Estudios originales

← vista completa

Publicado el 14 de marzo de 2024 | http://doi.org/10.5867/medwave.2024.02.2726

Developing a breast cancer screening decision aid in Spanish for average-risk women: a mixed methods study

Desarrollo de una herramienta en español para ayudar en la toma de decisiones del cribado de cáncer de mama para mujeres de riesgo promedio: un estudio de métodos mixtos

Paula Riganti, María Victoria Ruiz Yanzi, Juan Victor Ariel Franco, Josefina Chiodi, Mónica Regueiro, Karin Silvana Kopitowski

Esta obra de Medwave está bajo una licencia Creative Commons Atribución-NoComercial 3.0 Unported. Esta licencia permite el uso, distribución y reproducción del artículo en cualquier medio, siempre y cuando se otorgue el crédito correspondiente al autor del artículo y al medio en que se publica, en este caso, Medwave.

Autores

Paula Riganti

Family and Community Medicine Department, Hospital Italiano de Buenos Aires, Buenos Aires, Argentina

https://orcid.org/0000-0003-4200-9698

María Victoria Ruiz Yanzi

Family and Community Medicine Department, Hospital Italiano de Buenos Aires, Buenos Aires, Argentina

https://orcid.org/0000-0002-5871-2591

Juan Victor Ariel Franco

Institute of General Practice, Medical Faculty of the Heinrich-Heine-University Düsseldorf, Düsseldorf, Germany

https://orcid.org/0000-0003-0411-899X

Josefina Chiodi

Family and Community Medicine Department, Hospital Italiano de Buenos Aires, Buenos Aires, Argentina

https://orcid.org/0000-0003-1502-8500

Mónica Regueiro

Patient advocate, Buenos Aires, Argentina

Karin Silvana Kopitowski

Family and Community Medicine Department, Hospital Italiano de Buenos Aires, Buenos Aires, Argentina

karin.kopitowski@hospitalitaliano.org.ar

Perón 4190, Buenos Aires, Argentina C1199 ABB;

https://orcid.org/0000-0003-0939-0263

Figuras

Artículo no tiene figuras.

Foro

No hay mensajes

Historial

Citación Riganti P, Ruiz Yanzi MV, Franco JVA, Chiodi J, Regueiro M, Kopitowski KS. Desarrollo de una herramienta en español para ayudar en la toma de decisiones del cribado de cáncer de mama para mujeres de riesgo promedio: un estudio de métodos mixtos. Medwave 2024;24(2):e2726 doi: 10.5867/medwave.2024.02.2726

Envío 30/05/2023

Aceptación 20/02/2024

Publicación 14/03/2024

Indice

Métricas

Vistas en HTML

150

Descargas en PDF

15

Total

165

% Descargas en PDF

10%

Ver detalle

Notas

Palabras claves

Decision Making, Shared, Breast Neoplasms, Early Detection of Cancer, Decision Support Techniques

Referencias

  1. Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2018;68: 394–424. | CrossRef
  2. Gøtzsche PC, Jørgensen KJ. Screening for breast cancer with mammography. Cochrane Database Syst Rev. 2013;2013. | CrossRef
  3. Keating NL, Pace LE. Breast Cancer Screening in 2018. JAMA. 2018;319: 1814. | CrossRef
  4. Klarenbach S, Sims-Jones N, Lewin G, Singh H, Thériault G, Tonelli M, et al. Recommendations on screening for breast cancer in women aged 40-74 years who are not at increased risk for breast cancer. CMAJ. 2018;190: E1441–E1451. | CrossRef
  5. Smith RA, Andrews KS, Brooks D, Fedewa SA, Manassaram-Baptiste D, Saslow D, et al. Cancer screening in the United States, 2017: A review of current American Cancer Society guidelines and current issues in cancer screening. CA Cancer J Clin. 2017;67: 100–121. | CrossRef
  6. Siu AL, Force USPST. Screening for Breast Cancer: U.S. Preventive Services Task Force Recommendation Statement. Ann Intern Med. 2016;164: 279–96. | CrossRef
  7. Di Sivio AJ . Efectividad del tamizaje mamográfico en la reducción de la mortalidad por cáncer de mama. Ciudad Autónoma de Buenos Aires: Instituto Nacional del Cáncer. 2018. | Link
  8. Cancer Australia. In: Early detection of breast cancer | Cancer Australia [Internet]. 19 Mar 2020. | Link
  9. Makoul G, Clayman ML. An integrative model of shared decision making in medical encounters. Patient Educ Couns. 2006;60: 301–12. | CrossRef
  10. Grad R, Légaré F, Bell NR, Dickinson JA, Singh H, Moore AE, et al. Shared decision making in preventive health care: What it is; what it is not. Can Fam Physician. 2017;63: 682–684.
  11. Pillay J, MacGregor T, Hartling L. Breast Cancer Screening: Part B. Systematic review on women’s values and preferences to inform an update of the Canadian Task Force on Preventive Health Care 2011 guideline. Canadian Task Force on Preventive Health Care. 2017. | Link
  12. Sicsic J, Pelletier-Fleury N, Moumjid N. Women’s Benefits and Harms Trade-Offs in Breast Cancer Screening: Results from a Discrete-Choice Experiment. Value Health. 2018;21: 78–88. | CrossRef
  13. Hersch J, Barratt A, Jansen J, Irwig L, McGeechan K, Jacklyn G, et al. Use of a decision aid including information on overdetection to support informed choice about breast cancer screening: a randomised controlled trial. Lancet. 2015;385: 1642–52. | CrossRef
  14. Hersch J, Jansen J, Barratt A, Irwig L, Houssami N, Howard K, et al. Women’s views on overdiagnosis in breast cancer screening: a qualitative study. BMJ. 2013;346. | CrossRef
  15. Riganti P, Discacciati V, Terrasa S, Kopitowski K. Motivating Factors Influencing Women on Undergoing Mammograms for Breast Cancer Screening. Rev argent salud publica. 2018;9: 22–28. http://www.scielo.org.ar/scielo.php?script=sci_arttext&pid=S1853-810X2018000400004 | Link
  16. Stacey D, Légaré F, Lewis K, Barry MJ, Bennett CL, Eden KB, et al. Decision aids for people facing health treatment or screening decisions. Cochrane Database Syst Rev. 2017;4. | CrossRef
  17. Esmaeili M, Ayyoubzadeh SM, Javanmard Z, R Niakan Kalhori S. A systematic review of decision aids for mammography screening: Focus on outcomes and characteristics. Int J Med Inform. 2021;149: 104406. | CrossRef
  18. Martínez-Alonso M, Carles-Lavila M, Pérez-Lacasta MJ, Pons-Rodríguez A, Garcia M, Rué M, et al. Assessment of the effects of decision aids about breast cancer screening: a systematic review and meta-analysis. BMJ Open. 2017;7. | CrossRef
  19. Salgado MV, Kopitowski K, Barani M, Vietto V, Terrasa S. Overuse of Screening Mammography at an Academic Medical Center in Buenos Aires. Rev Argent Salud Pública. 2016;7: 7–11. | Link
  20. In: Patient decision aids – A to Z inventory of decision aids. Breast cancer results [Internet]. | Link
  21. Coulter A, Stilwell D, Kryworuchko J, Mullen PD, Ng CJ, van der Weijden T. A systematic development process for patient decision aids. BMC Med Inform Decis Mak. 2013;13 Suppl 2. | CrossRef
  22. Winters S, Martin C, Murphy D, Shokar NK. Breast Cancer Epidemiology, Prevention, and Screening. Prog Mol Biol Transl Sci. 2017;151: 1–32. | CrossRef
  23. Jacobsen MJ, O’Connor AM, Stacey D. In: Decisional Needs Assessment in Populations [Internet]. | Link
  24. Braun V, Clarke V. Using thematic analysis in psychology. Qualitative Research in Psychology. 2006;3: 77–101. | CrossRef
  25. Mathioudakis AG, Salakari M, Pylkkanen L, Saz-Parkinson Z, Bramesfeld A, Deandrea S, et al. Systematic review on women’s values and preferences concerning breast cancer screening and diagnostic services. Psychooncology. 2019;28: 939–947. | CrossRef
  26. Barratt A, Howard K, Irwig L, Salkeld G, Houssami N. Model of outcomes of screening mammography: information to support informed choices. BMJ. 2005;330: 936. | CrossRef
  27. Public Health Agency of Canada. Information on Mammography for Women Aged 40 and Older: A Decision Aid for Breast Cancer Screening in Canada. Chronic Disease Management Division, Centre for Chronic Disease Prevention and Control, Public Health Agency of Canada. 2009. | Link
  28. Independent UK Panel on Breast Cancer Screening. The benefits and harms of breast cancer screening: an independent review. Lancet. 2012;380: 1778–1786. | CrossRef
  29. Pace LE, Keating NL. A systematic assessment of benefits and risks to guide breast cancer screening decisions. JAMA. 2014;311: 1327–35. | CrossRef
  30. Pérez-Lacasta MJ, Martínez-Alonso M, Garcia M, Sala M, Perestelo-Pérez L, Vidal C, et al. Effect of information about the benefits and harms of mammography on women’s decision making: The InforMa randomised controlled trial. PLOS ONE. 2019;14. | CrossRef
  31. Faulkner L. Beyond the five-user assumption: benefits of increased sample sizes in usability testing. Behav Res Methods Instrum Comput. 2003;35: 379–83. | CrossRef
  32. Vargo J, Nesbit JC, Belfer K, Archambault A. Learning Object Evaluation: Computer-Mediated Collaboration And Inter-Rater Reliability. International Journal of Computers and Applications. 2003;25: 198–205. | CrossRef
  33. In: International Patient Decision Aids Standards (IPDAS) Collaboration [Internet]. Dec 2020. | Link
  34. Spina S, Lombardi V, Terrasa S, Kopitowski K, Villalón G. Cuán precisos son los principales diarios de Argentina al informar sobre los métodos de prevención del cáncer de mama. Rev Argent Salud Pública. 2018;9: 9–14. http://www.scielo.org.ar/scielo.php?pid=S1853-810X2018000400002&script=sci_arttext | Link
  35. Franco JVA. Shared Decision-Making - Beta testing protocol. Open Science Framework. 2021. | CrossRef
  36. Schrager S, Burnside E. Breast Cancer Screening in Primary Care: A Call for Development and Validation of Patient-Oriented Shared Decision-Making Tools. J Womens Health (Larchmt). 2019;28: 114–116. | CrossRef
  37. Trevena LJ, Bonner C, Okan Y, Peters E, Gaissmaier W, Han PKJ, et al. Current Challenges When Using Numbers in Patient Decision Aids: Advanced Concepts. Med Decis Making. 2021;41: 834–847. | CrossRef
  38. Meads C, Ahmed I, Riley RD. A systematic review of breast cancer incidence risk prediction models with meta-analysis of their performance. Breast Cancer Res Treat. 2012;132: 365–77. | CrossRef
  39. Nelson HD, Fu R, Cantor A, Pappas M, Daeges M, Humphrey L. Effectiveness of Breast Cancer Screening: Systematic Review and Meta-analysis to Update the 2009 U.S. Preventive Services Task Force Recommendation. Ann Intern Med. 2016;164: 244–55. | CrossRef
  40. Seely JM, Alhassan T. Screening for breast cancer in 2018-what should we be doing today? Curr Oncol. 2018;25: S115–S124. | CrossRef
  41. Tosteson ANA, Fryback DG, Hammond CS, Hanna LG, Grove MR, Brown M, et al. Consequences of false-positive screening mammograms. JAMA Intern Med. 2014;174: 954–61. | CrossRef
  42. Autier P, Boniol M, Koechlin A, Pizot C, Boniol M. Effectiveness of and overdiagnosis from mammography screening in the Netherlands: population based study. BMJ. 2017;359. | CrossRef
  43. Bleyer A, Welch HG. Effect of Three Decades of Screening Mammography on Breast-Cancer Incidence. Obstetrical & Gynecological Survey. 2013;68: 440–442. | CrossRef
  44. Ahmed H, Naik G, Willoughby H, Edwards AGK. Communicating risk. BMJ. 2012;344. | CrossRef
  45. Lang E, Bell NR, Dickinson JA, Grad R, Kasperavicius D, Moore AE, et al. Eliciting patient values and preferences to inform shared decision making in preventive screening. Can Fam Physician. 2018;64: 28–31.